Journal of the Association of Nurses in AIDS Care
Volume 17, Issue 1 , Pages 18-25 , January 2006

Dealing With the Obstacles in Adhering to Highly Active Antiretroviral Therapy

References 

  1. Ammassari A , Murri R , Pezzotti P , Trotta MP , Ravasio L , De Longis P , et al.   Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection . Journal of Acquired Immune Deficiency Syndromes . 2001;28:445–449
  2. Ammassari A , Trotta MP , Murri R , Castelli F , Narciso P , Noto P , et al.   Correlates and predictors of adherence to highly active antiretroviral therapy (Overview of published literature) . Journal of Acquired Immune Deficiency Syndromes . 2002;31(Suppl. 3):S123–S127
  3. Briggs JM , Drabek CA . Metabolic complications of HIV and AIDS . Orthopedic Nursing . 2001;20:41–50
  4. Cahn P , Pantaleo G , Gatell J , Squires K , Percival L , Piliero P , et al.   Atazanavir (A once-daily protease inhibitor with a superior lipid profile.) . 2002; (, May). Paper presented at the XIVth World Congress of Cardiology; Sydney, Australia.
  5. Chesney M . Adherence to HAART regimens . AIDS Patient Care and STDs . 2003;17:169–177
  6. Claxton AJ , Cramer J , Pierce C . A systematic review of the associations between dose regimens and medication compliance . Clinical Therapeutics . 2001;23:1296–1310
  7. Dubé MP , Stein JH , Aberg JA , Fichtenbaum CJ , Gerber JG , Tashima KT , et al.   Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy (Recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group) . Clinical Infectious Diseases . 2003;37:613–627
  8. Flores G . Culture and the patient-physician relationship (Achieving cultural competency in health care) . The Journal of Pediatrics . 2000;136:14–23
  9. Gallant JE , Staszewski S , Pozniak AL , DeJesus E , Suleiman JM , Miller MD , et al.   Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral-naive patients (A 3-year randomized trial) . Journal of the American Medical Association . 2004;292:191–201
  10. Gillett J , Pawluch D , Cain R . How people with HIV/AIDS manage and assess their use of complementary therapies (A qualitative analysis) . Journal of the Association of Nurses in AIDS Care . 2002;13:17–27
  11. Graney MJ , Bunting SM , Russell CK . HIV/AIDS medication adherence factors (Inner-city clinic patients’ self-reports) . Journal of the Tennessee Medical Association . 2003;96:73–78
  12. Gross R , Bilker WB , Friedman HM , Coyne JC , Strom BL . Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy . AIDS . 2002;16:1835–1837
  13. Haile BL , Landrum PA , Kotarba JA , Trimble D . Inner strength among HIV-infected women (Nurses can make a difference) . Journal of the Association of Nurses in AIDS Care . 2002;13:74–80
  14. Ickovics JR , Cameron A , Zackin R , Bassett R , Chesney M , Johnson VA , et al.   Consequences and determinants of adherence to antiretroviral medication (Results from Adult AIDS Clinical Trials Group protocol 370) . Antiviral Therapy . 2002;7:185–193
  15. Ka’opua LS , Mueller CW . Treatment adherence among Native Hawaiians living with HIV . Social Work . 2004;49:55–63
  16. Kirton CA . Promoting healthy behaviors in HIV primary care . Nurse Practitioner Forum . 2001;12:223–232
  17. Loughlin L , Jensen H . Patient adherence to medication for HIV . Professional Nurse . 2000;16:897–901
  18. Melbourne KM . The impact of religion on adherence with antiretrovirals . Journal of the Association of Nurses in AIDS Care . 1999;10:99–100
  19. Moyle G . Overcoming obstacles to the success of protease inhibitors in highly active antiretroviral therapy regimens . AIDS Patient Care and STDs . 2002;16:585–597
  20. Murphy DA , Roberts KJ , Hoffman D , Molina A , Lu MC . Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients . AIDS Care . 2003;15:217–230
  21. Panel on Clinical Practices for Treatment of HIV Infection (2004). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [updated March 23, 2004]. Retrieved September 17, 2004, from http://aidsinfo.nih.gov/guidelines/adult/AA_032304.pdf
  22. Parsons JT , Huszti HC , Crudder SO , Rich L , Mendoza J . Maintenance of safer sexual behaviours (Evaluation of a theory-based intervention for HIV seropositive men with haemophilia and their female partners) . Haemophilia . 2000;6:181–190
  23. Paterson DL , Swindells S , Mohr J , Brester M , Vergis EN , Squier C , et al.   Adherence to protease inhibitor therapy and outcomes in patients with HIV infection . Annals of Internal Medicine . 2000;133:21–30
  24. Piliero, P., Cahn, P., Pantaleo, G., Gatell, J. M., Squires, K., Percival, L., et al. (2002, February). Atazanavir: A once-daily protease inhibitor with a superior lipid profile: results of clinical trials beyond week 48 [poster 706-T]. Poster presented at the 9th Conference on Retroviruses and Opportunistic Infections, Seattle. Retrieved March 25, 2004, from http://www.retroconference.org/2002/Abstract/13827.htm
  25. Prescribing information (Viread (tenofovir disoproxil fumarate)) . In: Physicians’ Desk Reference . Montvale, NJ: Medical Economics, Inc; 2003;p. 1425–1428
  26. Prochaska JO , Redding CA , Harlow LL , Rossi JS , Velicer WF . The transtheoretical model of change and HIV prevention (A review) . Health Education Quarterly . 1994;21:471–486
  27. Trotta MP , Ammassari A , Melzi S , Zaccarelli M , Ladisa N , Sighinolfi L , et al.   Treatment-related factors and highly active antiretroviral therapy adherence . Journal of Acquired Immune Deficiency Syndromes . 2002;31(Suppl. 3):S128–S131
  28. Tucker JS , Burnam MA , Sherbourne CD , Kung FY , Gifford AL . Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection . American Journal of Medicine . 2003;114:573–580
  29. Williams AB . Adherence to highly active antiretroviral therapy . Nursing Clinics of North America . 1999;34:113–129
  30. Williams AB . Adherence to HIV regimens (ten vital lessons) . American Journal of Nursing . 2001;101:37–43

PII: S1055-3290(05)00308-0

doi: 10.1016/j.jana.2005.11.002

Journal of the Association of Nurses in AIDS Care
Volume 17, Issue 1 , Pages 18-25 , January 2006